Lupin launches Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 %

Lupin announced the launch of Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 %, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1 % is the generic equivalent of Taro Pharmaceuticals' Nystatin and Triamcinolone Acetonide Cream. It is indicated for the treatment of cutaneous candidiasis.

Nystatin and Triamcinolone Acetonide Cream had annual sales of $54.3 million in the US (IQVIA MAT September 2018).

Powered by Capital Market - Live News